Close
Nordic 9Nordic 9

+ND Capital (investor - Venture Capital)

United States nd.capital
See something wrong or missing? Let us know
Offices:San Jose

+ND Capital (f.k.a. NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences.

Average round investment:34.11M USD
Average number per year:1.7
Distribution: 2026 (1)2025 (1)2024 (2)2023 (4)2021 (1) See the entire list
Portfolio companies: United Kingdom Syndex BioSwitzerland Haya TherapeuticsUnited Kingdom Constructive Bio See the entire list
Mostly invests in: Switzerland Switzerland (5) Manufacturing (8)
See the entire list

Showing 3 of 10 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

+ND Capital mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to +ND Capital

Name Criteria
United States Hearst Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Transportation, Automotive, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Switzerland SkyViews Life Science
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Energize Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Transportation, Automotive, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland, Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Canada CTI Life Sciences
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Playground Global
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Isomer Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services, Transportation, Automotive, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
France Merieux Equity Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Switzerland Credit Suisse
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Transportation, Automotive, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Sweden DIG Investment
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Luxembourg New Space Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Transportation, Automotive, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top